pharmaceuticals: have names

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents industry
Weight: 0.48
, environment
Weight: 0.28
Siblings banking industry
Weight: 0.32
, automobile industry
Weight: 0.32
, chemicals
Weight: 0.31
, electronics
Weight: 0.31
, semiconductor
Weight: 0.30

Related properties

Property Similarity
have names 1.00
have two names 0.94
have strange names 0.87
deserve name 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.03
Rule weight: 0.13
Evidence weight: 0.34
Similarity weight: 0.77
Evidence: 0.91
¬ Remarkable(pharmaceuticals, have names)
Evidence: 0.72
¬ Remarkable(semiconductor, deserve name)

Remarkability from sibling implausibility

0.41
Rule weight: 0.60
Evidence weight: 0.88
Similarity weight: 0.77
Evidence: 0.39
Plausible(pharmaceuticals, have names)
Evidence: 0.72
Remarkable(semiconductor, deserve name)
Evidence: 0.73
¬ Plausible(semiconductor, deserve name)

Salient implies Plausible

0.17
Rule weight: 0.28
Evidence weight: 0.62
Similarity weight: 1.00
Evidence: 0.39
Plausible(pharmaceuticals, have names)
Evidence: 0.62
¬ Salient(pharmaceuticals, have names)

Similarity expansion

0.78
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.94
Evidence: 0.19
Typical(pharmaceuticals, have names)
Evidence: 0.04
¬ Typical(pharmaceuticals, have two names)
0.74
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.94
Evidence: 0.91
Remarkable(pharmaceuticals, have names)
Evidence: 0.96
¬ Remarkable(pharmaceuticals, have two names)
0.69
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.87
Evidence: 0.91
Remarkable(pharmaceuticals, have names)
Evidence: 0.70
¬ Remarkable(pharmaceuticals, have strange names)
0.69
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.94
Evidence: 0.39
Plausible(pharmaceuticals, have names)
Evidence: 0.24
¬ Plausible(pharmaceuticals, have two names)
0.65
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.94
Evidence: 0.62
Salient(pharmaceuticals, have names)
Evidence: 0.51
¬ Salient(pharmaceuticals, have two names)
0.48
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.87
Evidence: 0.62
Salient(pharmaceuticals, have names)
Evidence: 0.92
¬ Salient(pharmaceuticals, have strange names)
0.36
Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.87
Evidence: 0.39
Plausible(pharmaceuticals, have names)
Evidence: 0.84
¬ Plausible(pharmaceuticals, have strange names)
0.23
Rule weight: 0.85
Evidence weight: 0.30
Similarity weight: 0.87
Evidence: 0.19
Typical(pharmaceuticals, have names)
Evidence: 0.85
¬ Typical(pharmaceuticals, have strange names)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.62
Salient(pharmaceuticals, have names)
Evidence: 0.19
¬ Typical(pharmaceuticals, have names)
Evidence: 0.91
¬ Remarkable(pharmaceuticals, have names)

Typical implies Plausible

0.42
Rule weight: 0.48
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.39
Plausible(pharmaceuticals, have names)
Evidence: 0.19
¬ Typical(pharmaceuticals, have names)

Typicality and Rermarkability incompatibility between siblings

0.04
Rule weight: 0.14
Evidence weight: 0.34
Similarity weight: 0.77
Evidence: 0.91
¬ Remarkable(pharmaceuticals, have names)
Evidence: 0.72
¬ Typical(semiconductor, deserve name)